Metraipolis › archive › dc_ea72bac24ed5

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without… — Europe PMC PMID:40579995

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40579995
DOI
10.1093/neuonc/noaf156
License (as archived)
solo-consultazione
Archived
2026-11-09T16:22:50.398Z
SHA-256 of the archived text
d98a2cdb0335d5a20141010dde4ea6e3cb5b35e898b4fee8a345ab3db2e79551
Stable URL of this page
https://metraipolis.com/documento/dc_ea72bac24ed5

How to cite

Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without… — Europe PMC PMID:40579995 — Europe PMC (en), https://europepmc.org/article/MED/40579995 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea72bac24ed5 (Metraipolis archive dc_ea72bac24ed5, sha256 d98a2cdb0335d5a20141010dde4ea6e3cb5b35e898b4fee8a345ab3db2e79551)
BibTeX
@misc{dcea72bac24ed5,
  title = {Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without… — Europe PMC PMID:40579995},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40579995},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea72bac24ed5; sha256 d98a2cdb0335d5a20141010dde4ea6e3cb5b35e898b4fee8a345ab3db2e79551},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40579995. Agents can read the archived copy with the MCP tool read_document.